How Much Did Musely Raise?
Funding & Key Investors

Musely, a prominent player in the digital healthcare sector, has successfully secured a major strategic investment, bringing its total capital raised to $372.2M. This latest infusion of $350M underscores the company's robust growth trajectory and its ability to attract significant backing from institutional investors. By leveraging a direct-to-consumer model, Musely continues to redefine the intersection of telemedicine and personalized dermatology, positioning itself as a leader in the evolving landscape of remote medical services.

The company's funding history reflects a consistent path of expansion, beginning with its early-stage financing in 2014 and culminating in this recent major enterprise-level capital injection. This financial milestone provides the necessary resources to scale operations and further integrate its proprietary compounding pharmacy fulfillment with its digital consultation platform.

What is Musely?

Musely
Hospitals & Physicians ClinicsMedical Practice ManagementDrug Stores & Pharmacies

Musely operates as a sophisticated digital healthcare and telemedicine platform, specializing in personalized prescription skincare and hair treatments. By facilitating online consultations with licensed dermatology professionals, the company provides customized treatment plans for conditions such as acne, pigmentation, aging, rosacea, and hair loss. The platform distinguishes itself through a seamless integration of medical guidance and direct-to-consumer pharmacy fulfillment, ensuring that patients receive individualized formulations tailored to their specific clinical needs. This approach effectively bridges the gap between traditional dermatology and accessible, remote-first healthcare solutions.

How much funding has Musely raised?

Musely has raised a total of $372.2M across 3 funding rounds:

2014

Series A

$6.2M

Series B

$16M

2026

Other Financing Round

$350M

Series A (2014): $6.2M with participation from InnoSpring, GSR Ventures, and DCM Ventures

Series B (2014): $16M, investors not publicly disclosed

Other Financing Round (2026): $350M supported by General Catalyst

Key Investors in Musely

General Catalyst

General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors and stages, including healthcare and technology.

InnoSpring

InnoSpring is a research and development-focused investment entity that provides early-stage capital to innovative companies.

DCM Ventures

DCM Ventures is a global venture capital firm that partners with early-stage founders to build enduring technology companies through strategic guidance and operational support.

What's next for Musely?

With the successful closure of this major strategic investment, Musely is well-positioned to accelerate its market penetration and enhance its technological infrastructure. The company is expected to focus on expanding its range of dermatological offerings and optimizing its supply chain for compounded medications. By prioritizing ongoing treatment support and patient engagement, Musely aims to solidify its market position as a premier provider of personalized, dermatologist-level care. Future strategic initiatives will likely involve scaling its digital consultation capabilities and deepening its footprint within the broader telehealth ecosystem, ensuring sustained growth and long-term value creation for its stakeholders.

See full Musely company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Hospitals & Physicians ClinicsMedical Practice ManagementPhysicians ClinicsDental Practice Management
Dental Practice ManagementHospitals & Physicians Clinics
Hospitals & Physicians ClinicsMedical Practice Management

Frequently Asked Questions Regarding Musely Financial Insights

What are the most recent funding rounds that Musely has completed, and what were the funding rounds?
Musely has recently completed 3 funding rounds: Other Financing Round on May 1, 2026, Series B on Sep 10, 2014, Series A on Mar 5, 2014.
What is the total amount of funding Musely has raised to date?
Musely has raised a total of $372.2M in funding to date.
How many funding rounds has Musely completed?
Musely has completed 3 funding rounds.
How much funding did Musely raise in its most recent funding round?
Musely raised $350M in its most recent funding round.
Who are the lead investors in Musely's latest funding round?
The lead investor in Musely's latest funding round was General Catalyst. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Musely's history?
The largest funding round in Musely's history was $350M.
See more information about Musely